Canada finds no BPA risks in formula
This article was originally published in The Tan Sheet
Executive Summary
A Canadian survey of bisphenol A in canned powdered infant formulas determines the chemical used in the internal coating of food containers "is not expected to pose a health risk to the general population, including newborns and infants." Health Canada analyzed 38 formula products -- including Similac and Isomil from Abbott Labs, Enfamil from Mead Johnson and Good Start from Nestle -- and found BPA concentration below the average method detection limit of 0.13 nanograms per gram in all samples, according to a July report. One ng/g is equivalent to 1 part per billion. The report says FDA agrees with the Canadian agency's health risk conclusions, though Congress wants FDA to reassess BPA risks as part of pending food safety legislation (1"The Tan Sheet" June 22, 2009)
You may also be interested in...
BPA Study Added To Food Safety Bill, But Supplements Remain “Gray Area”
The House Energy and Commerce Committee added a requirement that FDA reassess bisphenol A risks before approving a food safety reform bill
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.